首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >ANTI PROLIFERATIVE ACTIVITY OF CALAMUS ROTANG AS A SPOTLIGHT ON EHRLICH’S ASCITES CARCINOMA TREATED PERITONEAL AS WELL AS SOLID TUMOR MODEL
【24h】

ANTI PROLIFERATIVE ACTIVITY OF CALAMUS ROTANG AS A SPOTLIGHT ON EHRLICH’S ASCITES CARCINOMA TREATED PERITONEAL AS WELL AS SOLID TUMOR MODEL

机译:蒲AM蒲的抗增殖活性是对艾氏腹膜癌和腹膜瘤以及实体瘤模型的关注

获取原文
           

摘要

Objective: Methanol extract of Calamus rotang (MECR) root was appraised as a spotlight for the candidate of anticancer activity through the vehicle (Ehrlich Ascites Carcinoma) on Swiss albino mice. Methods: In vitro cytotoxicity assay has been accessed by trypan blue and MTT assay. In vivo anticancer activity was done using EAC cells (2 × 10 6 ) where in each groups mice were 6. After treatment with MECR at the lower dose of 200 and higher dose of 400 mg/kg respectively for 9 d, half of the mice of each group were sacrificed and the rest were kept to check prolongation of life span. The anticancer potential of MECR was evaluated by tumor volume, viable and nonviable tumor cell count, tumor weight, hematological parameters, biochemical estimations and Furthermore, tissue antioxidant parameters. Besides, solid tumor activity was also inspected. Results: In MECR treated groups (200 and 400 mg/kg) tumor volume, packed cell volume and viable cell count was significantly lessened as compared to that of the EAC control group. Life span, most reliable criteria for anticancer study, increased quite surprisingly by 50% and 100% in a dose dependant manner while compared to EAC control group. The hematological, biochemical and liver tissue antioxidant parameter are significantly (p<0.05) restored along with solid tumor case study (solid tumor volume) towards the normal level after treatment with MECR. Conclusion: From the above study it can be inferred that the MECR has impressive anticancer activity in dose dependent way.
机译:目的:评价Cal蒲根(MECR)的甲醇提取物是通过媒介物(Ehrlich腹水癌)对瑞士白化病小鼠抗癌活性的候选者。方法:通过锥虫蓝和MTT法进行了体外细胞毒性测定。使用EAC细胞(2×10 6)进行体内抗癌活性,每组中的小鼠为6只。在分别以200毫克/千克的较低剂量和400毫克/千克的较高剂量用MECR处理9天后,一半的小鼠处死每组,其余的检查其寿命。通过肿瘤体积,存活和不存活的肿瘤细胞计数,肿瘤重量,血液学参数,生化估计以及组织抗氧化剂参数评估了MECR的抗癌潜力。此外,还检查了实体瘤活性。结果:与EAC对照组相比,在MECR治疗组(200和400 mg / kg)的肿瘤体积中,堆积细胞体积和活细胞计数显着降低。与EAC对照组相比,作为抗癌研究最可靠的标准的寿命以剂量依赖的方式令人惊讶地增加了50%和100%。 MECR治疗后,血液,生化和肝组织的抗氧化参数与实体瘤案例研究(实体瘤体积)一起显着(p <0.05)恢复到正常水平。结论:从以上研究可以推断出MECR具有剂量依赖性的令人印象深刻的抗癌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号